Literature DB >> 15135042

alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.

Anita Sidhu1, Christophe Wersinger, Philippe Vernier.   

Abstract

Parkinson's disease (PD) is a slow progressive neurodegenerative disorder. Recent evidence suggests a central role for alpha-synuclein, a protein of unknown function, in the genesis of PD. The phenomenon of selective degeneration of dopaminergic neurons in PD may be linked to the potential toxicity of dopamine itself and aberrations in the processes which regulate dopamine content may underlie the pathogenesis of this disease. Here, we review a vital role of alpha-synuclein in the modulation of dopamine transporter (DAT) function, and describe how disruption of this modulatory process permits increased re-uptake of high levels of intracellular dopamine by DAT, causing profound neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15135042     DOI: 10.1016/j.febslet.2004.03.063

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  52 in total

1.  Biochemical and morphological consequences of human α-synuclein expression in a mouse α-synuclein null background.

Authors:  Kavita Prasad; Elizabeth Tarasewicz; Pamela A Ohman Strickland; Michael O'Neill; Stephen N Mitchell; Kalpana Merchant; Samnang Tep; Kathryn Hilton; Akash Datwani; Manuel Buttini; Sarah Mueller-Steiner; Eric K Richfield
Journal:  Eur J Neurosci       Date:  2011-01-28       Impact factor: 3.386

2.  Specific antibodies to soluble alpha-synuclein conformations in intravenous immunoglobulin preparations.

Authors:  L M Patrias; A C Klaver; M P Coffey; D A Loeffler
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

Review 3.  Recognition of psychostimulants, antidepressants, and other inhibitors of synaptic neurotransmitter uptake by the plasma membrane monoamine transporters.

Authors:  Christopher K Surratt; Okechukwu T Ukairo; Suneetha Ramanujapuram
Journal:  AAPS J       Date:  2005-10-27       Impact factor: 4.009

4.  Regulation of genes involved in dopamine transporter modulation by acute cocaine in rat striatum.

Authors:  Cindie Courtin; Dominique Crete; Corinne Canestrelli; Florence Noble; Cynthia Marie-Claire
Journal:  Neurosci Lett       Date:  2006-02-03       Impact factor: 3.046

5.  Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons.

Authors:  Martin Lundblad; Mickael Decressac; Bengt Mattsson; Anders Björklund
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

6.  Partial regulation of serotonin transporter function by gamma-synuclein.

Authors:  Christophe Wersinger; Anita Sidhu
Journal:  Neurosci Lett       Date:  2009-02-21       Impact factor: 3.046

7.  Native Top-Down Mass Spectrometry and Ion Mobility MS for Characterizing the Cobalt and Manganese Metal Binding of α-Synuclein Protein.

Authors:  Piriya Wongkongkathep; Jong Yoon Han; Tae Su Choi; Sheng Yin; Hugh I Kim; Joseph A Loo
Journal:  J Am Soc Mass Spectrom       Date:  2018-06-27       Impact factor: 3.109

8.  RNA interference mediated silencing of alpha-synuclein in MN9D cells and its effects on cell viability.

Authors:  Dong-Mei Liu; Ling Jin; Hao Wang; Huan-Ying Zhao; Chun-Li Zhao; Hui Yang
Journal:  Neurosci Bull       Date:  2008-04       Impact factor: 5.203

9.  Exogenous α-Synuclein Monomers Alter Dopamine Metabolism in Murine Brain.

Authors:  Adriana Wawer; Ilona Joniec-Maciejak; Anna Sznejder-Pachołek; Joanna Schwenkgrub; Agnieszka Ciesielska; Dagmara Mirowska-Guzel
Journal:  Neurochem Res       Date:  2016-05-09       Impact factor: 3.996

10.  VMAT2 and dopamine neuron loss in a primate model of Parkinson's disease.

Authors:  Ming-Kai Chen; Hiroto Kuwabara; Yun Zhou; Robert J Adams; James R Brasić; Jennifer L McGlothan; Tatyana Verina; Neal C Burton; Mohab Alexander; Anil Kumar; Dean F Wong; Tomás R Guilarte
Journal:  J Neurochem       Date:  2007-11-05       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.